Sepideh Razi

1.3k total citations
39 papers, 920 citations indexed

About

Sepideh Razi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sepideh Razi has authored 39 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Sepideh Razi's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (6 papers) and Cancer Cells and Metastasis (4 papers). Sepideh Razi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (6 papers) and Cancer Cells and Metastasis (4 papers). Sepideh Razi collaborates with scholars based in Iran, India and United States. Sepideh Razi's co-authors include Nima Rezaei, Mahsa Keshavarz‐Fathi, Neda Khalili, Nastaran Khalili, Maryam Ebrahimi, Rangarirai Makuku, Parnian Jabbari, Parmida Sadat Pezeshki, Soroush Najdaghi and Massimiliano Mazzone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Breast Cancer Research and Treatment.

In The Last Decade

Sepideh Razi

35 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sepideh Razi Iran 14 337 323 294 151 117 39 920
Mahsa Keshavarz‐Fathi Iran 16 431 1.3× 411 1.3× 416 1.4× 149 1.0× 115 1.0× 36 1.2k
Jian-An Huang China 13 304 0.9× 318 1.0× 271 0.9× 126 0.8× 169 1.4× 49 852
Fei Mo China 15 269 0.8× 345 1.1× 364 1.2× 88 0.6× 100 0.9× 33 1.0k
Hang Yu China 19 209 0.6× 610 1.9× 260 0.9× 266 1.8× 221 1.9× 94 1.4k
Xiaokai Zhang China 16 120 0.4× 285 0.9× 200 0.7× 125 0.8× 71 0.6× 44 755
Božena Smolková Slovakia 20 241 0.7× 619 1.9× 107 0.4× 372 2.5× 80 0.7× 67 1.2k
Min Ren China 16 107 0.3× 276 0.9× 187 0.6× 134 0.9× 53 0.5× 45 902
Yuan Song China 17 190 0.6× 178 0.6× 475 1.6× 44 0.3× 78 0.7× 57 896
Guoying Zhu China 18 320 0.9× 703 2.2× 136 0.5× 186 1.2× 63 0.5× 55 1.4k
Wanjun Zhang China 12 145 0.4× 340 1.1× 111 0.4× 118 0.8× 81 0.7× 42 852

Countries citing papers authored by Sepideh Razi

Since Specialization
Citations

This map shows the geographic impact of Sepideh Razi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepideh Razi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepideh Razi more than expected).

Fields of papers citing papers by Sepideh Razi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sepideh Razi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepideh Razi. The network helps show where Sepideh Razi may publish in the future.

Co-authorship network of co-authors of Sepideh Razi

This figure shows the co-authorship network connecting the top 25 collaborators of Sepideh Razi. A scholar is included among the top collaborators of Sepideh Razi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sepideh Razi. Sepideh Razi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Razi, Sepideh, et al.. (2025). Chemoimmunotherapy in Advanced Biliary Tract Cancers: A Meta-Analysis of Clinical Outcomes. Biomedicines. 13(9). 2099–2099.
2.
Razi, Sepideh, et al.. (2025). The role of CXC chemokines and receptors in breast cancer. Clinical and Experimental Medicine. 25(1). 128–128. 1 indexed citations
3.
4.
Razi, Sepideh, et al.. (2024). The role of interleukin-2 in graft-versus-host disease pathogenesis, prevention and therapy. Cytokine. 183. 156723–156723. 1 indexed citations
5.
Razi, Sepideh, et al.. (2024). Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer. Clinical Biochemistry. 129. 110767–110767. 6 indexed citations
6.
Razi, Sepideh, et al.. (2023). Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment. International Immunopharmacology. 119. 110215–110215. 13 indexed citations
7.
Razi, Sepideh, et al.. (2023). NLRP3 inflammatory pathway. Can we unlock depression?. Brain Research. 1822. 148644–148644. 15 indexed citations
8.
Ghafelehbashi, Robabehbeygom, et al.. (2022). Nanoimmunoengineering strategies in cancer diagnosis and therapy. Clinical & Translational Oncology. 25(1). 78–90. 4 indexed citations
9.
Loskog, Angelica, et al.. (2022). The signaling and the metabolic differences of various CAR T cell designs. International Immunopharmacology. 114. 109593–109593. 15 indexed citations
10.
Razi, Sepideh, et al.. (2022). AMPK’s double-faced role in advanced stages of prostate cancer. Clinical & Translational Oncology. 24(11). 2064–2073. 9 indexed citations
11.
Darbeheshti, Farzaneh, Sepideh Kadkhoda, Mahsa Keshavarz‐Fathi, et al.. (2022). Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness. BMC Cancer. 22(1). 668–668. 12 indexed citations
12.
Makuku, Rangarirai, Homa Seyedmirzaei, Marcarious M. Tantuoyir, et al.. (2022). Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article. International Immunopharmacology. 105. 108580–108580. 6 indexed citations
13.
Makuku, Rangarirai, Neda Khalili, Sepideh Razi, Mahsa Keshavarz‐Fathi, & Nima Rezaei. (2021). Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy. Journal of Immunology Research. 2021. 1–15. 90 indexed citations
14.
Razi, Sepideh, et al.. (2021). A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications. Translational Lung Cancer Research. 10(4). 1889–1916. 130 indexed citations
15.
Razi, Sepideh, et al.. (2021). TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends?. Cytokine. 150. 155772–155772. 11 indexed citations
16.
Nowroozi, Ali, Sepideh Razi, Kamal Kant Sahu, et al.. (2021). COVID-19 in Patients with Cancer. Advances in experimental medicine and biology. 1318. 315–331. 2 indexed citations
17.
Gouravani, Mahdi, Nastaran Khalili, Sepideh Razi, et al.. (2020). The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Review of Clinical Immunology. 16(2). 175–187. 28 indexed citations
18.
Razi, Sepideh, et al.. (2020). Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. Cancer Immunology Immunotherapy. 69(9). 1673–1697. 60 indexed citations
19.
Razi, Sepideh, et al.. (2020). DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner. Clinical and Experimental Medicine. 21(1). 139–147. 15 indexed citations
20.
Ebrahimi, Maryam, Neda Khalili, Sepideh Razi, et al.. (2020). Effects of lead and cadmium on the immune system and cancer progression. Journal of Environmental Health Science and Engineering. 18(1). 335–343. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahsa Keshavarz‐Fathi Breakdown of academic impact, for papers by Jian-An Huang Breakdown of academic impact, for papers by Fei Mo Breakdown of academic impact, for papers by Hang Yu Breakdown of academic impact, for papers by Xiaokai Zhang Breakdown of academic impact, for papers by Božena Smolková Breakdown of academic impact, for papers by Min Ren Breakdown of academic impact, for papers by Yuan Song Breakdown of academic impact, for papers by Guoying Zhu Breakdown of academic impact, for papers by Wanjun Zhang
Rankless by CCL
2026